The drug stock cure is debated
Wichita Eagle, KS - 52 minutes ago
... The New York company's earnings are expected to soar more than 50 percent
this year on strong sales of antidepressant drugs Celexa and Lexapro. ...

The drug stock cure is debated
Miami Herald, FL - 56 minutes ago
... The New York company's earnings are expected to soar more than 50 percent
this year on strong sales of antidepressant drugs Celexa and Lexapro. ...

New Drugs Spur Forest Labs Profits
Newsday - 24 Oct 2002
... Wall Street seems to think so since the antidepressant, Lexapro, is gaining market
share and the company has several new drugs that are expected to hit the ...

New Drugs Spur Forest Labs Profits
Newsday - 24 Oct 2002
... Wall Street seems to think so since the antidepressant, Lexapro, is gaining market
share and the company has several new drugs that are expected to hit the ...

New Drugs Spur Forest Labs Profits
WFTV, FL - 24 Oct 2002
... Wall Street seems to think so since the antidepressant, Lexapro, is gaining market
share and the company has several new drugs that are expected to hit the ...

New Drugs Spur Forest Labs Profits
Austin American Statesman, TX - 24 Oct 2002
... Wall Street seems to think so since the antidepressant, Lexapro, is gaining market
share and the company has several new drugs that are expected to hit the ...

New drugs spur forest labs profits
Wichita Eagle, KS - 24 Oct 2002
... Wall Street seems to think so since the antidepressant, Lexapro, is gaining market
share and the company has several new drugs that are expected to hit the ...

New drugs spur forest labs profits
Fort Wayne News Sentinel, IN - 24 Oct 2002
... Wall Street seems to think so since the antidepressant, Lexapro, is gaining market
share and the company has several new drugs that are expected to hit the ...

New drugs spur forest labs profits
San Jose Mercury News, CA - 24 Oct 2002
... Wall Street seems to think so since the antidepressant, Lexapro, is gaining market
share and the company has several new drugs that are expected to hit the ...

New Drugs Spur Forest Labs Profits
ABC News - 24 Oct 2002
... Wall Street seems to think so since the antidepressant, Lexapro, is gaining market
share and the company has several new drugs that are expected to hit the ...

Forest Labs Earnings Expected to Rise
Newsday - 23 Oct 2002
... Wall Street seems to think so since the antidepressant, Lexapro, is gaining market
share and the company has several new drugs that are expected to hit the ...

Forest Labs Earnings Expected to Rise
WFTV, FL - 23 Oct 2002
... Wall Street seems to think so since the antidepressant, Lexapro, is gaining market
share and the company has several new drugs that are expected to hit the ...

Forest Labs Earnings Expected to Rise
Austin American Statesman, TX - 23 Oct 2002
... Wall Street seems to think so since the antidepressant, Lexapro, is gaining market
share and the company has several new drugs that are expected to hit the ...

Forest Labs Earnings Expected to Rise
ABC News - 23 Oct 2002
... Wall Street seems to think so since the antidepressant, Lexapro, is gaining market
share and the company has several new drugs that are expected to hit the ...

Forest Labs Earnings Expected to Rise
Sarasota Herald-Tribune, FL - 23 Oct 2002
... Wall Street seems to think so since the antidepressant, Lexapro, is gaining market
share and the company has several new drugs that are expected to hit the ...

Forest Labs Earnings Expected to Rise
Seattle Post Intelligencer, WA - 23 Oct 2002
... Wall Street seems to think so since the antidepressant, Lexapro, is gaining market
share and the company has several new drugs that are expected to hit the ...

Delay Doesn ’ t Cut Down Forest Stock
Newsday - 22 Oct 2002
... Kingdom. Forest is best-known for its drugs to treat depression, Celexa
and Lexapro, which now make up about 72 percent of its sales. ...

Delay Doesn ’ t Cut Down Forest Stock
Newsday - 22 Oct 2002
... Kingdom. Forest is best-known for its drugs to treat depression, Celexa
and Lexapro, which now make up about 72 percent of its sales. ...

Delay Doesn ’ t Cut Down Forest Stock
Newsday - 22 Oct 2002
... Kingdom. Forest is best-known for its drugs to treat depression, Celexa
and Lexapro, which now make up about 72 percent of its sales. ...

New Lundbeck drug no better than rival-Danish agency
Reuters AlertNet, UK - 21 Oct 2002
... under the name of Lexapro, initiated a quicker response than its rival,
it would be natural to choose Cipralex for new patients. ...

RESEARCH ALERT-Prudential lifts Forest Labs estimates
Reuters AlertNet, UK - 16 Oct 2002
... for drugmaker Forest Laboratories Inc. , citing strong sales of its
antidepressants Celexa and Lexapro. Anderson raised his fiscal ...

RESEARCH ALERT-Prudential lifts Forest Labs estimates
Forbes - 16 Oct 2002
... Forest Laboratories Inc. (nyse: FRX - news - people), citing strong
sales of its antidepressants Celexa and Lexapro. Anderson raised ...

Forest Profit Soars on Celexa Sales
ABC News - 15 Oct 2002
... Celexa sales jumped 50 percent to $386.4 million and its new antidepressant, Lexapro,
generated sales of $21.7 million in its first quarter on the market. ...

Forest Profit Soars on Celexa Sales
ABC News - 15 Oct 2002
... Celexa sales jumped 50 percent to $386.4 million and its new antidepressant, Lexapro,
generated sales of $21.7 million in its first quarter on the market. ...

Forest Profit Soars on Celexa Sales
Reuters, UK - 15 Oct 2002
... Celexa sales jumped 50 percent to $386.4 million and its new antidepressant, Lexapro,
generated sales of $21.7 million in its first quarter on the market. ...

Forest Profit Soars on Celexa Sales
ABC News - 15 Oct 2002
... Celexa sales jumped 50 percent to $386.4 million and its new antidepressant, Lexapro,
generated sales of $21.7 million in its first quarter on the market. ...

Forest Profit Soars on Celexa Sales
Reuters, UK - 15 Oct 2002
... Celexa sales jumped 50 percent to $386.4 million and its new antidepressant, Lexapro,
generated sales of $21.7 million in its first quarter on the market. ...

Forest Profit Soars on Celexa Sales
ABC News - 15 Oct 2002
... Celexa sales jumped 50 percent to $386.4 million and its new antidepressant, Lexapro,
generated sales of $21.7 million in its first quarter on the market. ...

Forest Profit Soars on Celexa Sales
Washington Post, DC - 15 Oct 2002
... Forest has said it intends to use its sales force and marketing budget
to promote its new antidepressant, Lexapro. Forest has essentially ...

Forest Profit Soars on Celexa Sales
ABC News - 15 Oct 2002
... Forest has said it intends to use its sales force and marketing budget
to promote its new antidepressant, Lexapro. Forest has essentially ...

Forest Profit Soars on Celexa Sales
ABC News - 15 Oct 2002
... Forest has said it intends to use its sales force and marketing budget
to promote its new antidepressant, Lexapro. Forest has essentially ...

Forest Profit Soars on Celexa Sales
Reuters, UK - 15 Oct 2002
... Forest has said it intends to use its sales force and marketing budget
to promote its new antidepressant, Lexapro. Forest has essentially ...

Forest 2nd-quarter profit soars on Celexa sales
Reuters AlertNet, UK - 15 Oct 2002
... Forest said it intends to use its sales force and marketing budget to
promote its new antidepressant, Lexapro. Forest has essentially ...

Lundbeck US antidepressants share up
Reuters AlertNet, UK - 15 Oct 2002
COPENHAGEN, Oct 15 (Reuters) - Danish pharmaceutical group Lundbeck's antidepressant
Celexa and its successor Lexapro had a total market share of new ...

Lundbeck US antidepressants share up
Forbes - 15 Oct 2002
COPENHAGEN, Oct 15 (Reuters) - Danish pharmaceutical group Lundbeck's antidepressant
Celexa and its successor Lexapro had a total market share of new ...

Wanted: Kleptomaniacs for Stanford
San Francisco Examiner, CA - 10 Oct 2002
... The school's psychiatry department is set to test a new antidepressant drug,
Lexapro, on kleptos, to see whether the medication tempers their disorder. ...